Penn Medicine researchers have identified genetic conditions in a large percent of adults admitted to the intensive care unit ...

Additionally, previous studies did not incorporate ctDNA testing in the surveillance setting, and, in our study, we demonstrated the feasibility of using a personalized, tumor-informed ctDNA assay for ...

Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court greenlight.

In 2026, the diagnostic testing market is projected to be valued at USD 213.03 billion, reflecting a compound annual growth rate (CAGR) of 3% since 2024. The market is expected to grow from $203.24 ...

The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge greenlighted the sale of the remnants of the firm, including its wealth of ...

The program, named DNA Discovery with TriHealth, involves a simple blood test that analyzes a person's DNA to assess their risk for certain diseases.